These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9845518)

  • 21. Prolactin suppression enhances the effects of perioperative donor-specific blood transfusions on graft survival.
    Martinelli GP; Liu H; Clarke WP; Heisenleder DJ; Knight RJ
    J Surg Res; 1996 Aug; 64(2):190-7. PubMed ID: 8812632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.
    Hu H; Zhu X; Joshi S; Lu L; Xia CQ; Patel JM
    PLoS One; 2015; 10(5):e0124705. PubMed ID: 25933390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation.
    Toyokawa H; Nakao A; Bailey RJ; Nalesnik MA; Kaizu T; Lemoine JL; Ikeda A; Tomiyama K; Papworth GD; Huang L; Demetris AJ; Starzl TE; Murase N
    Liver Transpl; 2008 Mar; 14(3):346-57. PubMed ID: 18306376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide.
    Tomita Y; Yoshikawa M; Zhang QW; Shimizu I; Okano S; Iwai T; Yasui H; Nomoto K
    J Immunol; 2000 Jul; 165(1):34-41. PubMed ID: 10861032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
    Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
    Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant IFN-gamma abrogates allograft tolerance induced by donor-specific blood transfusion by restoring alloantibody production.
    Josien R; Cuturi MC; Douillard P; Heslan M; Heslan JM; Soulillou JP
    Eur J Immunol; 1999 Jan; 29(1):317-26. PubMed ID: 9933114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A strategy for generating consistent long-term donor-specific tolerance to solid organ allografts.
    Levy AE; Alexander JW; Babcock GF
    Transpl Immunol; 1997 Jun; 5(2):83-8. PubMed ID: 9269029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of operational tolerance by random blood transfusion combined with anti-CD4 antibody therapy. A protocol with significant clinical potential.
    Bushell A; Morris PJ; Wood KJ
    Transplantation; 1994 Jul; 58(2):133-9. PubMed ID: 8042231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunomodulatory effect of nuclear factor-κB inhibition by dehydroxymethylepoxyquinomicin in combination with donor-specific blood transfusion.
    Goto R; Yamashita K; Aoyagi T; Ueki S; Uno M; Oura T; Kobayashi N; Igarashi R; Shibasaki S; Wakayama K; Hirokata G; Shibata T; Zaitsu M; Umezawa K; Ozaki M; Todo S
    Transplantation; 2012 Apr; 93(8):777-86. PubMed ID: 22357176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of donor-specific unresponsiveness to rat cardiac allograft by donor leukocytes and cyclosporine.
    Oluwole SF; Fawwaz RA; Reemtsma K; Hardy MA
    Transplantation; 1988 Jun; 45(6):1131-5. PubMed ID: 3289153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allograft tolerance induced by cyclophosphamide without prior inoculation of donor cells--immune suppression and redirection.
    Gao ZH; Lazarovits AI; Wang J; Xing J; Garcia B; Kellersmann R; Kelvin D; Zhong R
    Transpl Immunol; 2000 Mar; 8(1):65-73. PubMed ID: 10834612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells.
    Lehmann M; Graser E; Risch K; Hancock WW; Müller A; Kuttler B; Hahn HJ; Kupiec-Weglinski JW; Brock J; Volk HD
    Transplantation; 1997 Oct; 64(8):1181-7. PubMed ID: 9355837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat.
    Ko S; Deiwick A; Jäger MD; Dinkel A; Rohde F; Fischer R; Tsui TY; Rittmann KL; Wonigeit K; Schlitt HJ
    Nat Med; 1999 Nov; 5(11):1292-7. PubMed ID: 10545996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance induction in rats, using a combination of anti-CD154 and donor splenocytes, given once on the day of transplantation.
    Sebille F; Brouard S; Petzold T; Degauque N; Guillet M; Moreau A; Benjamin CD; Soulillou JP
    Transplantation; 2003 Jan; 75(2):169-72. PubMed ID: 12548117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
    Motoyama K; Arima T; Yu S; Lehmann M; Flye MW
    Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examination of the mechanisms responsible for tolerance induction after intrathymic inoculation of allogeneic bone marrow.
    Odorico JS; O'Connor T; Campos L; Barker CF; Posselt AM; Naji A
    Ann Surg; 1993 Oct; 218(4):525-31; discussion 531-3. PubMed ID: 8215643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of infectious tolerance after donor-specific transfusion and rat heart transplantation.
    Kataoka M; Margenthaler JA; Ku G; Flye MW
    J Immunol; 2003 Jul; 171(1):204-11. PubMed ID: 12816999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.